Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

PRIMO 2024

07–10 February 2024 | Lihue, HI

PRIMO 2024

07–10 February 2024 | Lihue, HI
Challenges in treating brain tumors: enhancing drug delivery and targeting infiltrating cells 4:24
Challenges in treating brain tumors: enhancing drug delivery and targeting infiltrating cells
Glenn Lesser • 12 Mar 2024
Multidisciplinary approaches in treating brain tumors: current landscape and future directions 4:06
Multidisciplinary approaches in treating brain tumors: current landscape and future directions
Glenn Lesser • 12 Mar 2024
Transformative potential of CAR-T cell therapy: current challenges and future Directions 3:17
Transformative potential of CAR-T cell therapy: current challenges and future Directions
Manmeet Ahluwalia • 8 Mar 2024
Exploring immunotherapy trends in the uterine cancer treatment landscape 0:35
Exploring immunotherapy trends in the uterine cancer treatment landscape
Ritu Salani • 29 Feb 2024
Advancing uterine cancer management 0:45
Advancing uterine cancer management
Ritu Salani • 29 Feb 2024
The future of immunotherapy evolving in the management of uterine cancer 1:33
The future of immunotherapy evolving in the management of uterine cancer
Ritu Salani • 29 Feb 2024
Broadening horizons in immuno-oncology: insights from PRIMO 2024 1:09
Broadening horizons in immuno-oncology: insights from PRIMO 2024
Ritu Salani • 29 Feb 2024
Personalizing therapy for high-risk HR+ breast cancer: insights from monarchE and NATALEE trials 1:32
Personalizing therapy for high-risk HR+ breast cancer: insights from monarchE and NATALEE trials
William J. Gradishar • 28 Feb 2024
Exploring endocrine therapy innovations for high-risk hormone receptor-positive breast cancer 1:30
Exploring endocrine therapy innovations for high-risk hormone receptor-positive breast cancer
William J. Gradishar • 28 Feb 2024
Advances in the teatment of high-risk early-stage hormone receptor positive breast cancer 4:01
Advances in the teatment of high-risk early-stage hormone receptor positive breast cancer
William J. Gradishar • 28 Feb 2024
Role of immunotherapy in advanced endometrial cancer: recent developments and future directions 0:50
Role of immunotherapy in advanced endometrial cancer: recent developments and future directions
Ritu Salani • 29 Feb 2024
Implications of phase III trials in endometrial cancer: dMMR patients and immunotherapy 1:08
Implications of phase III trials in endometrial cancer: dMMR patients and immunotherapy
Ritu Salani • 29 Feb 2024
Evolution of gene therapy in oncology 1:37
Evolution of gene therapy in oncology
Manmeet Ahluwalia • 8 Mar 2024
Advancements and challenges in CAR-T cell therapy 2:53
Advancements and challenges in CAR-T cell therapy
Manmeet Ahluwalia • 29 Feb 2024
Groundbreaking research in gliomas: insights from the INDIGO trial 7:23
Groundbreaking research in gliomas: insights from the INDIGO trial
Glenn Lesser • 12 Mar 2024
The evolution of immunotherapy in brain tumor treatment 6:00
The evolution of immunotherapy in brain tumor treatment
Glenn Lesser • 12 Mar 2024
The content of VJOncology is intended for healthcare professionals